BiotechTube
Home/Transneural Therapeutics/Charmaine Lykins, MBA
CL

Charmaine Lykins, MBA

Chief Executive Officer

Transneural Therapeutics

Therapeutic Areas

PsychiatryNeurology

Transneural Therapeutics Pipeline

DrugIndicationPhase
TN-001Neuropsychiatric Disorders (e.g., MDD, PTSD)Pre-clinical
Undisclosed Program 2Neuropsychiatric DisordersPre-clinical
Undisclosed Program 3Neuropsychiatric DisordersPre-clinical

Leadership Team at Transneural Therapeutics

MA
Mark A. Demitrack, MD
Chief Research and Development Officer
DF
David Frawley
Strategic Advisor
View full Transneural Therapeutics profile